Articles by Disease (Autoimmune Diseases)

Endothelial Expression of MHC Class II Molecules in Autoimmune Disease

Journal: Current Pharmaceutical Design
Volume: 10
Page: 129-143
Author(s): Carl Turesson

Endothelial Chemokines in Autoimmune Disease

Journal: Current Pharmaceutical Design
Volume: 10
Page: 145-154
Author(s): Kent W. Christopherson II and Robert A. Hromas

Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders

Journal: Current Pharmaceutical Design
Volume: 10
Page: 155-161
Author(s): Mae-Xhum Wong and Denise E. Jackson

Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide

Journal: Current Pharmaceutical Design
Volume: 10
Page: 213-221
Author(s): Y. S. Lin, C. F. Lin, H. Y. Lei, H. S. Liu, T. M. Yeh, S. H. Chen and C. C. Liu

α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]

Journal: Current Medicinal Chemistry
Volume: 11
Page: 241-252
Author(s): Yoshihiro Hayakawa, Dale I. Godfrey and Mark J. Smyth

The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1
Page: 53-74
Author(s): Patrick Englebienne

Deaza Analogs of Folic Acid as Antitumor Agents

Journal: Current Pharmaceutical Design
Volume: 9
Page: 2615-2625
Author(s): R. L. Kisliuk

Naturally Arising CD25+CD4+ Regulatory T Cells in Maintaining Immunologic Self-Tolerance and Preventing Autoimmune Disease

Journal: Current Molecular Medicine
Volume: 3
Page: 693-706
Author(s): Takeshi Takahashi and Shimon Sakaguchi

Molecular Mimicry in Autoimmune Neurological Disease after Viral Infection

Journal: Current Medicinal Chemistry
Volume: 10
Page: 1939-1943
Author(s): Bart O. Roep

Regulation of B-Cell Activation by Complement Receptors CD21 and CD35

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1849-1860
Author(s): Anna Erdei, Jozsef Prechl, Andrea Isaak and Eszter Molnar